The Advisors and Observers team at Nucleai provides strategic guidance and critical insights to enhance the company's AI-powered spatial biology platform. Advisors bring their expertise to inform decision-making and guide clinical trial strategies, while Observers offer impartial, data-driven insights to ensure objective evaluation of research outcomes and collaborations. Together, they help maximize the impact of Nucleai’s platform on drug development and patient care.